Thomas S. Kupper

Add links
From Wikipedia, the free encyclopedia

Thomas S. Kupper is an American physician, academic, and clinician. His work with clinical and research experience spans dermatology, cutaneous oncology, and immunology. He is the Thomas B. Fitzpatrick Professor at Harvard Medical School, and chairs the Departments of Dermatology at Brigham and Women's Hospital. He also leads the Cutaneous Oncology Disease Center at the Dana Farber Cancer Institute.[1]

Education[edit]

Thomas Seth Kupper obtained his BA in Chemistry from UCLA. He received his MD from the Yale School of Medicine in 1981. From Yale-New Haven Hospital, he completed a residency in General Surgery, followed by postdoctoral research in Immunology, and a residency in Dermatology. He obtained Board Certification in Dermatology in 1989.[2]

Career[edit]

Kupper began his career as Assistant Professor of Dermatology at Yale School of Medicine, then became Associate Professor of Medicine and Pathology at Washington University School of Medicine. He was recruited to Harvard Medical School as the Thomas B. Fitzpatrick Associate Professor of Dermatology. He became full Professor and Division Chief of Dermatology in 1995 and led the transition of Dermatology from Division of Medicine to freestanding independent hospital Department in 2001.[3][4][5]

Research[edit]

After discovering and describing keratinocyte cytokines in late 1980s/early 1990s, he has spent the past two decades years focusing on skin homing T cells, from reporting the molecular structure of Cutaneous Lymphocyte Antigen[6] to co-discovering that non-inflamed skin contained large numbers of memory T cells.[7] A subset of these are now known as “tissue resident memory T cells” or TRM, and he demonstrated that these T cells 1) can be generated by skin vaccination,[8] 2) provide immune protection in the absence of circulating T cells,[9] 3) have a diverse T cell repertoire mirrored by circulating memory T cells,[10] and 4) utilize unique metabolic strategies to survive in the periphery,[11] and represent a prognostic factor in melanoma.[12][13] In the diagnosis and treatment of Cutaneous T Cell Lymphoma, which he defined as a malignancy of skin resident and circulating T cells.[14] This observation has led to mechanism-based therapies,[1] more precise diagnosis[15] and prognosis.[16] Over the years this work has been supported by a MERIT award from the NIAID, a Transformative R01 Award from the Office of the NIH Director, and multiple R01's from the NIAID, NIAMS, and NCI.[17]

Awards and honors[edit]

He was elected as Fellow of the American Association of Academic Scientists and member of the American Academy of Physicians in 2008. He was elected as a member of the American Society for Clinical Investigation. He won the American Skin Association Autoimmune and Inflammatory Skin Disorders Research Achievement Award in 2014. He is an honorary fellow of the Japanese Society for Investigative Dermatology, the Korean Society for Investigative Dermatology, the Swiss Dermatologic Association, and the Austrian Society for Investigative Dermatology.[18][19]

Publications[edit]

  • The vast majority of CLA+ T cells are fellow resident in normal skin.[7]
  • Skin infection generates non-migratory memory CD8+ T(RM) cells providing global skin immunity.[9]
  • Dependence of skin TRM on exogenous lipids.[11]
  • Identification of T cells influencing melanoma prognosis.[12]
  • The emerging role of resident memory T cells in protective immunity and inflammatory disease.[13]

References[edit]

  1. ^ a b "Thomas S. Kupper, MD". hsci.harvard.edu. Retrieved 2021-07-31.
  2. ^ "Thomas S Kupper, MD - Brigham and Women's Hospital". physiciandirectory.brighamandwomens.org. Retrieved 2021-07-31.
  3. ^ "emedevents.com".
  4. ^ "Brigham Research Institute | Thomas Seth Kupper, MD". Retrieved 2021-07-31.
  5. ^ "Dr. Thomas Kupper, MD – Boston, MA | Dermatology on Doximity". Doximity. Retrieved 2021-07-31.
  6. ^ Fuhlbrigge, Robert C.; Kieffer, J. David; Armerding, Dieter; Kupper, Thomas S. "Cutaneous lymphocyte antigen is a specialized form of PSGL-1 expressed on skin-homing T cells". Nature. 389 (6654): 978–981. doi:10.1038/40166. ISSN 1476-4687.
  7. ^ a b Clark, Rachael A.; Chong, Benjamin; Mirchandani, Nina; Brinster, Nooshin K.; Yamanaka, Kei-ichi; Dowgiert, Rebecca K.; Kupper, Thomas S. (2006-04-01). "The Vast Majority of CLA+ T Cells Are Resident in Normal Skin". The Journal of Immunology. 176 (7): 4431–4439. doi:10.4049/jimmunol.176.7.4431. ISSN 0022-1767. PMID 16547281.
  8. ^ Liu, Luzheng; Zhong, Qiong; Tian, Tian; Dubin, Krista; Athale, Shruti K.; Kupper, Thomas S. (February 2010). "Epidermal injury and infection during poxvirus immunization is crucial for the generation of highly protective T cell–mediated immunity". Nature Medicine. 16 (2): 224–227. doi:10.1038/nm.2078. ISSN 1546-170X. PMC 3070948. PMID 20081864.
  9. ^ a b Jiang, Xiaodong; Clark, Rachael A.; Liu, Luzheng; Wagers, Amy J.; Fuhlbrigge, Robert C.; Kupper, Thomas S. (March 2012). "Skin infection generates non-migratory memory CD8+ TRM cells providing global skin immunity". Nature. 483 (7388): 227–231. doi:10.1038/nature10851. ISSN 1476-4687. PMC 3437663. PMID 22388819.
  10. ^ Gaide, Olivier; Emerson, Ryan O.; Jiang, Xiaodong; Gulati, Nicholas; Nizza, Suzanne; Desmarais, Cindy; Robins, Harlan; Krueger, James G.; Clark, Rachael A.; Kupper, Thomas S. (June 2015). "Common clonal origin of central and resident memory T cells following skin immunization". Nature Medicine. 21 (6): 647–653. doi:10.1038/nm.3860. ISSN 1546-170X. PMC 4632197. PMID 25962122.
  11. ^ a b Pan, Youdong; Tian, Tian; Park, Chang Ook; Lofftus, Serena Y.; Mei, Shenglin; Liu, Xing; Luo, Chi; O’Malley, John T.; Gehad, Ahmed; Teague, Jessica E.; Divito, Sherrie J. (March 2017). "Survival of tissue-resident memory T cells requires exogenous lipid uptake and metabolism". Nature. 543 (7644): 252–256. doi:10.1038/nature21379. ISSN 1476-4687. PMC 5509051. PMID 28219080.
  12. ^ a b Pruessmann, Wiebke; Rytlewski, Julie; Wilmott, James; Mihm, Martin C.; Attrill, Grace H.; Dyring-Andersen, Beatrice; Fields, Paul; Zhan, Qian; Colebatch, Andrew J.; Ferguson, Peter M.; Thompson, John F. (February 2020). "Molecular analysis of primary melanoma T cells identifies patients at risk for metastatic recurrence". Nature Cancer. 1 (2): 197–209. doi:10.1038/s43018-019-0019-5. ISSN 2662-1347. PMC 7725220. PMID 33305293.
  13. ^ a b Park, Chang Ook; Kupper, Thomas S. (July 2015). "The emerging role of resident memory T cells in protective immunity and inflammatory disease". Nature Medicine. 21 (7): 688–697. doi:10.1038/nm.3883. ISSN 1546-170X. PMC 4640452. PMID 26121195.
  14. ^ Campbell, James J.; Clark, Rachael A.; Watanabe, Rei; Kupper, Thomas S. (2010-08-05). "Sézary syndrome and mycosis fungoides arise from distinct T-cell subsets: a biologic rationale for their distinct clinical behaviors". Blood. 116 (5): 767–771. doi:10.1182/blood-2009-11-251926. ISSN 0006-4971. PMC 2918332. PMID 20484084.
  15. ^ Clark, Rachael A.; Watanabe, Rei; Teague, Jessica E.; Schlapbach, Christoph; Tawa, Marianne C.; Adams, Natalie; Dorosario, Andrew A.; Chaney, Keri S.; Cutler, Corey S.; LeBoeuf, Nicole R.; Carter, Joi B. (2012-01-18). "Skin Effector Memory T Cells Do Not Recirculate and Provide Immune Protection in Alemtuzumab-Treated CTCL Patients". Science Translational Medicine. 4 (117): 117ra7–117ra7. doi:10.1126/scitranslmed.3003008. ISSN 1946-6234. PMC 3373186. PMID 22261031.
  16. ^ Kirsch, Ilan R.; Watanabe, Rei; O’Malley, John T.; Williamson, David W.; Scott, Laura-Louise; Elco, Christopher P.; Teague, Jessica E.; Gehad, Ahmed; Lowry, Elizabeth L.; LeBoeuf, Nicole R.; Krueger, James G. (2015-10-07). "TCR sequencing facilitates diagnosis and identifies mature T cells as the cell of origin in CTCL". Science Translational Medicine. 7 (308): 308ra158–308ra158. doi:10.1126/scitranslmed.aaa9122. ISSN 1946-6234. PMC 4765389. PMID 26446955.
  17. ^ "Thomas S. Kupper, MD - DF/HCC". www.dfhcc.harvard.edu. Retrieved 2021-07-31.
  18. ^ "Tanioku Kihei Memorial Award - The Japanese Society for Investigative Dermatology". www.jsid.org. Retrieved 2021-08-06.
  19. ^ "Thomas Seth Kupper - Professor, Chairman of Dermatology in Boston, Massachusetts, United States Of America | eMedEvents". eMedEvents.com. Retrieved 2021-08-18.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Thomas_S._Kupper&oldid=1211050095"